Leslie's' ROCE trend is concerning as returns shrink despite reinvestment. The 64% stock decline over three years may reflect investor pessimism. Underlying trends suggest better investment opportunities elsewhere.
A meaty post market decline after retailers benefited from a bounce today.$Leslie's(LESL.US)$, the 2nd largrst holding, tanked -22% in post market. $标普零售指数ETF-SPDR(XRT.US)$
While Leslie's CEO remains positive about long-term growth, Seeking Alpha's Quant Rating reveals a less optimistic market view, categorising Leslie's as Strong Sell or Sell since March.
Steven Ortega, Leslie's Board Chairman, is pleased to welcome Seth, adding his experience will aid company growth. Seth Estep is eager to leverage his expertise to drive growth, recognizing Leslie's success in the pool and spa aftermarket industry.
Upgrades •$Funko(FNKO.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $28 (from $25) •$西南航空(LUV.US)$: Raymond James Upgrades to Strong Buy from Outperform - PT $55 (from $57) •$大都会人寿(MET.US)$: Wolfe Research Upgrades to Outperform from Peerperform •$MGIC Investment(MTG.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $16 (from $15) •$Snowflake(SNOW.US)$: JPMorgan Upgrades to Overweigh...
Mcsnacks H Tupack楼主AllSeeingGuy:
$VIZIO (VZIO.US)$is in a reversal. It has too many shares in a range of less than 40% difference. MM’s Will up the bids to larger spreads. Just like when it gets over 80% they shorten the spreads and bid it down. Since there are so few shares available they don’t want to get stuck in a squeeze situation where it’s that close because of the 20.00 option contracts get bid out it would squeeze from 19.15. Where it’s at now.
Leslie's股票讨论区
$标普零售指数ETF-SPDR(XRT.US)$
利息费用近3年持续下滑,2022年占营业利润的12.7%,负担中等。
2023前两季度营收萎缩1.2%,营业利润则受成本费用双重增长影响而亏损0.52亿,净利润亏损0.62亿。
目前市盈率6.3,市盈率TTM提高到8.6,可以多观察几个季度再判断。
Current watch ⚡️⚡️
$前进保险(PGR.US)$$Nikola(NKLA.US)$$哈门那(HUM.US)$$PainReform(PRFX.US)$$旗际汽车(CJET.US)$$Biodexa Pharmaceuticals(BDRX.US)$$Leslie's(LESL.US)$$英伟达(NVDA.US)$$Elevance Health(ELV.US)$$SAI TECH Global(SAI.US)$
专栏Top upgrades and downgrades on 6/23: HD, LOW, LUV, WE and more
• $Funko(FNKO.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $28 (from $25)
• $西南航空(LUV.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $55 (from $57)
• $大都会人寿(MET.US)$ : Wolfe Research Upgrades to Outperform from Peerperform
• $MGIC Investment(MTG.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $16 (from $15)
• $Snowflake(SNOW.US)$ : JPMorgan Upgrades to Overweigh...
专栏Top upgrades and downgrades on 4/4
• $DCP Midstream(DCP.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $Leslie's(LESL.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $罗技(LOGI.US)$ : Goldman Sachs Upgrades to Buy from Neutral
• $蔚来(NIO.US)$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $Ollie's Bargain Outlet(OLLI.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $Oric Pharmaceuticals(ORIC.US)$ : Citigro...
Stocks upgraded to buys
$Jounce Therapeutics Inc(JNCE.US)$ buyin 7.20 sell 13.15.
$Leslie's(LESL.US)$
buy in 22.38 sell 26.00
$DXC Technology(DXC.US)$
buy in 34.40 sell 43.30
$西麦斯(CX.US)$
buy in 7.62 sell 8.66
$Braskem(BAK.US)$
in breakout still.
暂无评论